UNSPSC 51312405: Chloropyramine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H20ClN3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWA92Z14NN, chemically known as 1,2-ethanediamine, n-((4-chlorophenyl)methyl)-n,n-dimethyl-n-2-pyridinyl- (9ci) but more generally known as chloropyramine hydrochloride, which bears US NIH Compound Identifier 25295. European Medicines Agency schedules Chloropyramine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01233MIG.

UNSPSC 51312405 Chloropyramine hydrochloride is a Commodity code under which state and local governments procure pharmaceutical products, though recent solicitation activity shows limited direct purchasing of this specific antihistamine compound. Instead, state and local buyers are using broader pharmaceutical procurement vehicles to source generic drugs, OTC products, and emergency medications through cooperative purchasing alliances and direct-to-manufacturer initiatives. The issuing bodies soliciting under or alongside this code include county health departments, state health and human services commissions, and multistate cooperative purchasing organizations. Seminole County, Florida, for example, recently sought naloxone and drug deactivation systems through competitive bidding to support community health initiatives, while the Texas Health and Human Services Commission issued an RFI to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, represents the most active recent procurement vehicle, having issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and an effective date of July 1, 2026; this procurement spans participating state and local facilities across Minnesota and Oregon and requires vendors to maintain relationships with designated wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson. Activity concentrates in Florida and Texas, with the broader cooperative purchasing model extending to the Pacific Northwest. Vendors pursuing this code should expect evaluation weighted heavily on price competitiveness (75 percent), compliance with cGMP and DSCSA standards, EDI capability, and maintenance of $5 million commercial general liability coverage and $2 million network security and privacy liability coverage. The Seminole County opportunity (IFB60459723LAS, due July 26, 2023) required quarterly deliveries and fixed-fee pricing on a two-year initial term with one-year renewal option.